HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tie-Bang Kang Selected Research

Neoplasms (Cancer)

1/2020BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma.
1/2019METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.
1/2019Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancer.
1/2016Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
12/2015Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma.
10/2015Effect of latent membrane protein 1 expression on overall survival in Epstein-Barr virus-associated cancers: a literature-based meta-analysis.
4/2015High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
12/2014Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells.
5/2014Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
1/2014Oncogenic roles of carbonic anhydrase IX in human nasopharyngeal carcinoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tie-Bang Kang Research Topics

Disease

16Nasopharyngeal Carcinoma
01/2021 - 12/2009
15Neoplasms (Cancer)
01/2020 - 12/2009
12Neoplasm Metastasis (Metastasis)
01/2023 - 04/2011
3Carcinogenesis
01/2019 - 04/2015
3Colorectal Neoplasms (Colorectal Cancer)
11/2018 - 04/2013
2Stomach Neoplasms (Stomach Cancer)
01/2023 - 01/2019
1Lymphatic Metastasis
01/2023
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020
1Carcinoma (Carcinomatosis)
10/2018
1Pancreatitis
01/2016
1Nasopharyngitis
12/2015
1Lung Neoplasms (Lung Cancer)
12/2014
1Hypoxia (Hypoxemia)
01/2014
1Esophageal Squamous Cell Carcinoma
05/2012
1Lymphoma (Lymphomas)
12/2009

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2014
4Indicators and Reagents (Reagents)IBA
05/2014 - 04/2011
3Cisplatin (Platino)FDA LinkGeneric
01/2023 - 01/2014
3RNA (Ribonucleic Acid)IBA
01/2023 - 10/2018
3Biomarkers (Surrogate Marker)IBA
04/2018 - 11/2015
2Fumarate Hydratase (Fumarase)IBA
01/2023 - 01/2019
2Carbonic Anhydrase IXIBA
01/2021 - 01/2014
2DNA (Deoxyribonucleic Acid)IBA
12/2015 - 11/2015
2Serum AlbuminIBA
11/2015 - 01/2014
2Small Interfering RNA (siRNA)IBA
12/2014 - 07/2012
2ChromatinIBA
12/2014 - 12/2009
2Oncogene Proteins (Oncogene Protein)IBA
05/2014 - 12/2009
2S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
05/2012 - 03/2011
1Therapeutic UsesIBA
01/2020
1OTX015IBA
01/2020
1N-methyladenosineIBA
01/2019
1MethyltransferasesIBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
11/2018
1Protein Isoforms (Isoforms)IBA
10/2018
13' Untranslated Regions (3' UTR)IBA
10/2018
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2016
1nafamostatIBA
01/2016
1Membrane Proteins (Integral Membrane Proteins)IBA
10/2015
1MicroRNAs (MicroRNA)IBA
04/2015
1Transforming Growth Factor beta (TGF-beta)IBA
04/2015
1Carrier Proteins (Binding Protein)IBA
12/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
12/2014
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
05/2014
1GlobulinsIBA
01/2014
1AlbuminsIBA
01/2014
1PaxillinIBA
04/2013
1Messenger RNA (mRNA)IBA
04/2013
1Interleukin-8 (Interleukin 8)IBA
07/2012
1HLA-G Antigens (HLA G)IBA
01/2012
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2012
1serglycinIBA
04/2011
1Proteoglycans (Proteoglycan)IBA
04/2011
1Polycomb-Group ProteinsIBA
12/2009

Therapy/Procedure

5Drug Therapy (Chemotherapy)
01/2023 - 07/2015
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
03/2016 - 01/2014
2Chemoradiotherapy
01/2018 - 11/2015
2Neoadjuvant Therapy
11/2015 - 11/2015
1Induction Chemotherapy
01/2018
1Therapeutics
10/2015
1Precision Medicine
04/2011